Supports Clinical Advancement of Remedisc™ for Degenerative Disc Disease NEW YORK, April 20, 2021 /PRNewswire/ -- Spine BioPharma, LLC, a company committed to developing non-opiate, non-surgical therapies for the treatment of pain and...

NEW YORK--(BUSINESS WIRE)--OrbiMed, a leading life sciences investment firm, announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million...

BELGRADE, Mont., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT) (the Company), a global medical technology company focused on surgical solutions for the treatment of...